9-120952821-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001735.3(C5):c.4949G>A(p.Arg1650Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001735.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C5 | NM_001735.3 | c.4949G>A | p.Arg1650Lys | missense_variant | 41/41 | ENST00000223642.3 | |
C5-OT1 | NR_148450.1 | n.11G>A | non_coding_transcript_exon_variant | 1/2 | |||
C5 | NM_001317163.2 | c.4967G>A | p.Arg1656Lys | missense_variant | 41/41 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C5 | ENST00000223642.3 | c.4949G>A | p.Arg1650Lys | missense_variant | 41/41 | 1 | NM_001735.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251366Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135844
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461258Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 726974
GnomAD4 genome AF: 0.000177 AC: 27AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 11, 2022 | The c.4949G>A (p.R1650K) alteration is located in exon 41 (coding exon 41) of the C5 gene. This alteration results from a G to A substitution at nucleotide position 4949, causing the arginine (R) at amino acid position 1650 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 1650 of the C5 protein (p.Arg1650Lys). This variant is present in population databases (rs145613662, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with C5-related conditions. ClinVar contains an entry for this variant (Variation ID: 1432048). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt C5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at